We assessed the accuracy of plasma P‐tau217 and plasma P‐tau181 (and for comparison CSF P‐tau217 and CSF P‐tau181) to predict tau‐PET and CSF Aβ positivity in DLB or PDD. This evidence concerns the gene MAPT and Lewy body dementia.